• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoindoles and derivatives Isoindolones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoindoles and derivatives Isoindolines Isoindolones

Professional Introduction to 3-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)propanenitrile (CAS No. 3589-45-5)

3-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)propanenitrile is a significant compound in the field of chemical and pharmaceutical research, characterized by its complex molecular structure and diverse potential applications. This compound, identified by the CAS number 3589-45-5, has garnered attention due to its structural uniqueness and its role in various synthetic pathways. The presence of multiple functional groups, including a nitrile group and an isoindole core, makes it a versatile intermediate in organic synthesis and drug development.

The compound's structure is particularly noteworthy for its potential in medicinal chemistry. The 1,3-dioxo-2,3-dihydro-1H-isoindol moiety is a key feature that contributes to its reactivity and biological activity. This moiety has been studied extensively for its role in the synthesis of bioactive molecules, including potential pharmacophores in drug discovery. The nitrile group further enhances its utility as a building block in the construction of more complex molecules, making it valuable for researchers exploring new therapeutic agents.

Recent advancements in synthetic chemistry have highlighted the importance of such intermediates in the development of novel drugs. The ability to functionalize the 3-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)propanenitrile scaffold allows for the creation of diverse derivatives with tailored biological properties. This flexibility has been exploited in several research groups aiming to develop new treatments for various diseases.

In particular, the isoindole core has shown promise in the development of antimicrobial and anti-inflammatory agents. Studies have demonstrated that modifications around this core can lead to compounds with enhanced efficacy against resistant strains of bacteria and reduced toxicity profiles. The nitrile group also plays a crucial role in these interactions, often serving as a hydrogen bond acceptor or participating in π-stacking interactions with biological targets.

The compound's reactivity makes it an attractive candidate for further exploration in catalytic processes. Researchers have leveraged its structural features to develop novel catalysts for asymmetric synthesis, which is crucial for producing enantiomerically pure drugs with minimal side effects. The ability to generate chiral centers at specific positions within the molecule is essential for many pharmaceutical applications.

The pharmaceutical industry has been particularly interested in derivatives of 3-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)propanenitrile due to their potential as kinase inhibitors. Kinases are enzymes involved in numerous cellular processes, and their dysregulation is associated with various diseases, including cancer. By designing molecules that specifically interact with these enzymes, researchers aim to develop targeted therapies that can modulate cellular signaling pathways.

Additionally, the compound has been investigated for its role in materials science. Its unique electronic properties make it a candidate for use in organic semiconductors and light-emitting diodes (OLEDs). The ability to fine-tune its electronic characteristics through structural modifications opens up possibilities for developing advanced materials with applications in electronics and optoelectronics.

The synthesis of 3-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)propanenitrile involves multi-step organic reactions that require precise control over reaction conditions. Advanced techniques such as flow chemistry have been employed to improve yield and purity while reducing waste generation. These methods align with the growing emphasis on sustainable chemistry practices within the industry.

Ongoing research continues to uncover new applications for this compound. Collaborative efforts between academic institutions and pharmaceutical companies are driving innovation by combining expertise in synthetic chemistry with computational modeling to predict and validate new derivatives' biological activity. This interdisciplinary approach is essential for accelerating the discovery of next-generation therapeutics.

The future prospects for 3-(1,3-dioxo-2,3-dihydro-1H-indol-2-yl)propanenitrile are promising as more researchers explore its potential. As our understanding of molecular interactions deepens, so does our ability to design compounds with specific therapeutic effects. This compound stands as a testament to the power of molecular design in addressing complex biological challenges.

• 3184-61-0(4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)butanenitrile)
• 5323-50-2(2-Propylisoindoline-1,3-dione)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)